VIVELIX

vivelix-logo

Vivelix is committed to delivering innovative products and services that improve the lives of patients suffering from gastrointestinal and liver diseases.Their suffix, “LIX” pays homage to their past experience and rich heritage. Their founders are former leaders of Salix Pharmaceuticals, Inc. a global leader in the treatment of GI diseases, and who made Salix products some of the world’s most prescribed gastroenterology and hepatology treatments. Collectively, the Vivelix leadership team has delivered over 165 years of scientific, clinical, manufacturing, and commercial success.

#SimilarOrganizations #People #Website #More

VIVELIX

Social Links:

Industry:
Health Care Pharmaceutical

Founded:
2016-01-01

Address:
Hamilton, Hamilton, Bermuda

Country:
Bermuda

Website Url:
http://www.vivelix.com

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Pound Sterling Japanese Yen DNS.COM


Similar Organizations

acea-therapeutics-logo

ACEA Therapeutics

ACEA Therapeutics develops and delivers innovative treatments to improve the lives of patients with life-threatening diseases.

clario-logo

Clario

Clario delivers the endpoint technology solutions for clinical trials.

Current Employees Featured

not_available_image

Enoch Bortey
Enoch Bortey Founder & CDO @ Vivelix
Founder & CDO
2016-09-01

Founder


not_available_image

Enoch Bortey

Official Site Inspections

http://www.vivelix.com

  • Host name: 195.35.49.44
  • IP address: 195.35.49.44
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Vivelix"

Vivelix - Crunchbase Company Profile & Funding

Vivelix is a deliver innovative products and services that improve the lives of patients suffering from gastrointestinal and liver diseases. There is no recent news or activity for this profile. …See details»

Vivelix Pharmaceuticals - Craft

Vivelix Pharmaceuticals is a company delivering products and services that improve the lives of patients suffering from gastrointestinal and liver diseases. It focuses on gastroenterology and …See details»

Vivelix Pharmaceuticals Corp. - VentureRadar

Website: http://www.vivelix.com. Vivelix Pharmaceuticals licenses, develops and commercializes gastroenterology and hepatology treatments. NCBiotech Company Directory. Associated …See details»

Vivelix Pharmaceuticals Corp. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Vivelix Pharmaceuticals Corp. of Morrisville, NC. Get the latest business insights from Dun & Bradstreet.See details»

Vivelix - Company Profile - Tracxn

Oct 25, 2024 · Vivelix is a specialty pharmaceutical company that licenses, develops and commercializes drug candidates. The main focus of the company is gastroenterology and …See details»

Vivelix Pharmaceuticals - Products, Competitors, Financials, …

Vivelix delivers products and services for patients suffering from gastrointestinal and liver diseases. Use the CB Insights Platform to explore Vivelix Pharmaceuticals's full profile.See details»

Vivelix - Contacts, Employees, Board Members, Advisors & Alumni

Vivelix has 1 current employee profile, Founder & CDO Enoch Bortey. Vivelix is a deliver innovative products and services that improve the lives of patients suffering from …See details»

Bill Forbes, PharmD | Beyond Air Inc. (XAIR)

Forbes currently serves as the founder, President and Chief Executive Officer of Vivelix Pharmaceuticals, Ltd., a clinical-stage pharmaceutical company focused on gastrointestinal …See details»

Vivelix Pharmaceuticals CEO and Key Executive Team - Craft

Vivelix Pharmaceuticals's Founder & President and Chief Executive Officer is William P. Forbes. Other executives include Enoch B. Bortey, Founder & Chief Development Officer; Srini …See details»

Vivelix - Crunchbase

Vivelix is a deliver innovative products and services that improve the lives of patients suffering from gastrointestinal and liver diseases.See details»

William P. Forbes - Director at Hallux - The Org

Currently, Bill is the Founder & President, CEO of Vivelix Pharmaceuticals, a venture backed clinical stage company focused on bringing new, innovative therapies for GI disorders to market.See details»

Idera Pharmaceuticals and Vivelix Pharmaceuticals, Ltd.

Nov 28, 2016 · Vivelix Pharmaceuticals, Ltd. is a newly formed, privately held specialty pharmaceutical company focused on licensing, developing and commercializing …See details»

Idera Pharmaceuticals and Vivelix Pharmaceuticals Enter Into …

Nov 28, 2016 · Idera Pharmaceuticals and Vivelix Pharmaceuticals today announced that they have entered into an exclusive license and collaboration agreement granting Vivelix worldwide …See details»

Idera Pharmaceuticals and Vivelix Pharmaceuticals, Ltd enter into ...

Nov 28 (Reuters) - Idera Pharmaceuticals Inc : * Press release - Idera Pharmaceuticals and Vivelix Pharmaceuticals, Ltd. Enter into exclusive license agreement for the worldwide rights to...See details»

Vivelix Pharmaceuticals, Ltd. | Insights

Dec 8, 2016 · Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions …See details»

Enoch Bortey - Founder & Chief Development Officer - Vivelix

Founder & Chief Development Officer at Vivelix Pharmaceuticals · Experience: Vivelix Pharmaceuticals · Location: Chapel Hill · 412 connections on LinkedIn. View Enoch Bortey’s …See details»

Idera sells licensing rights to shelved autoimmune drug

Nov 28, 2016 · Vivelix is shelling out $15 million upfront for IMO-9200, a drug that works to inhibit expression of a few members of a protein class called toll-like receptors (TLRs). The deal also …See details»

Management - Heron Therapeutics

Oct 10, 2024 · Prior to joining Heron, Dr. Forbes served as the Chief Development Officer at Trevi Therapeutics, Inc. from 2021 to 2022. From 2016 to 2020, Dr. Forbes served as the President …See details»

Vivelix Gains Global Rights to Idera GI Disorder Candidate

Nov 28, 2016 · Idera Pharmaceuticals has granted Vivelix Pharmaceuticals exclusive worldwide rights to the nonmalignant gastrointestinal disorder candidate IMO-9200, under a licensing …See details»

Chiesi USA Chosen as One of Fortune’s 25 Best Small and Medium ...

CARY, N.C., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group …See details»

linkstock.net © 2022. All rights reserved